Skip to content
Open access · CC-BY via OpenAlex

Gut Microbial Postbiotics as Potential Therapeutics for Lymphoma: Proteomics Insights of the Synergistic Effects of Nisin and Urolithin B Against Human Lymphoma Cells

Ahmad K. Al-Khazaleh, Muhammad A. Alsherbiny, Gerald W Münch, Dennis Chang, Deep Jyoti Bhuyan

International Journal of Molecular Sciences · 2025 · ▲ 6 citations

Abstract

Lymphoma continues to pose a significant global health burden, highlighting the urgent need for novel therapeutic strategies. Recent advances in microbiome research have identified gut-microbiota-derived metabolites, or postbiotics, as promising candidates in cancer therapy. This study investigates the antiproliferative and mechanistic effects of two postbiotics, Nisin (N) and Urolithin B (UB), individually and in combination, against the human lymphoma cell line HKB-11. Moreover, this study evaluated cytotoxic efficacy and underlying molecular pathways using a comprehensive experimental approach, including the Alamar Blue assay, combination index (CI) analysis, flow cytometry, reactive oxygen species (ROS) quantification, and bottom-up proteomics. N and UB displayed notable antiproliferative effects, with IC50 values of 1467 µM and 87.56 µM, respectively. Importantly, their combination at a 4:6 ratio demonstrated strong synergy (CI = 0.09 at IC95), significantly enhancing apoptosis (p ≤ 0.0001) and modulating oxidative stress. Proteomic profiling revealed significant regulation of key proteins related to lipid metabolism, mitochondrial function, cell cycle control, and apoptosis, including upregulation of COX6C (Log2FC = 2.07) and downregulation of CDK4 (Log2FC = −1.26). These findings provide mechanistic insights and underscore the translational potential of postbiotics in lymphoma treatment. Further preclinical and clinical investigations are warranted to explore their role in therapeutic regimens.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/ijms26146829
Canonical
link ↗
Fetched
2026-10-17 MST

Cite this

APA
Al-Khazaleh, A.K., Alsherbiny, M.A., Münch, G.W., Chang, D., &amp; Bhuyan, D.J. (2025). Gut Microbial Postbiotics as Potential Therapeutics for Lymphoma: Proteomics Insights of the Synergistic Effects of Nisin and Urolithin B Against Human Lymphoma Cells. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms26146829
Vancouver
Al-Khazaleh AK, Alsherbiny MA, Münch GW, Chang D, Bhuyan DJ. Gut Microbial Postbiotics as Potential Therapeutics for Lymphoma: Proteomics Insights of the Synergistic Effects of Nisin and Urolithin B Against Human Lymphoma Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146829.
BibTeX
@article{ahmad2025GutMic, title = {Gut Microbial Postbiotics as Potential Therapeutics for Lymphoma: Proteomics Insights of the Synergistic Effects of Nisin and Urolithin B Against Human Lymphoma Cells}, author = {Ahmad K. Al-Khazaleh and Muhammad A. Alsherbiny and Gerald W Münch and Dennis Chang and Deep Jyoti Bhuyan}, journal = {International Journal of Molecular Sciences}, year = {2025}, doi = {10.3390/ijms26146829}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings